These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice. Jin Q, Qiao C, Li J, Xiao B, Li J, Xiao X. Skelet Muscle; 2019 May 27; 9(1):16. PubMed ID: 31133057 [Abstract] [Full Text] [Related]
15. A canine minidystrophin is functional and therapeutic in mdx mice. Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X. Gene Ther; 2008 Aug 28; 15(15):1099-106. PubMed ID: 18432277 [Abstract] [Full Text] [Related]
16. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Wagner KR, McPherron AC, Winik N, Lee SJ. Ann Neurol; 2002 Dec 28; 52(6):832-6. PubMed ID: 12447939 [Abstract] [Full Text] [Related]
17. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Watchko J, O'Day T, Wang B, Zhou L, Tang Y, Li J, Xiao X. Hum Gene Ther; 2002 Aug 10; 13(12):1451-60. PubMed ID: 12215266 [Abstract] [Full Text] [Related]